Latest Insider Transactions at Horizon Therapeutics Public LTD CO (HZNP)
This section provides a real-time view of insider transactions for Horizon Therapeutics Public LTD CO (HZNP). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Horizon Therapeutics Public Ltd Co to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Horizon Therapeutics Public Ltd Co's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 05
2021
|
Daniel A. Camardo EVP and President, U.S. |
SELL
Payment of exercise price or tax liability
|
Direct |
9,230
-17.58%
|
$673,790
$73.28 P/Share
|
|
Jan 05
2021
|
Daniel A. Camardo EVP and President, U.S. |
BUY
Exercise of conversion of derivative security
|
Direct |
20,614
+28.19%
|
-
|
|
Jan 05
2021
|
Michael A. Des Jardin EVP, Technical Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
50,658
-30.64%
|
$1,823,688
$36.1 P/Share
|
|
Jan 05
2021
|
Michael A. Des Jardin EVP, Technical Operations |
BUY
Grant, award, or other acquisition
|
Direct |
60,313
+26.73%
|
-
|
|
Jan 05
2021
|
Michael A. Des Jardin EVP, Technical Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
41,615
+28.38%
|
-
|
|
Jan 05
2021
|
Irina Konstantinovsky EVP, Chief Human Resources Off |
SELL
Payment of exercise price or tax liability
|
Direct |
44,184
-28.05%
|
$3,225,432
$73.28 P/Share
|
|
Jan 05
2021
|
Irina Konstantinovsky EVP, Chief Human Resources Off |
BUY
Grant, award, or other acquisition
|
Direct |
60,314
+27.69%
|
-
|
|
Jan 05
2021
|
Irina Konstantinovsky EVP, Chief Human Resources Off |
BUY
Exercise of conversion of derivative security
|
Direct |
39,196
+28.73%
|
-
|
|
Jan 05
2021
|
Andy Pasternak EVP, Chief Strategy Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,526
-28.43%
|
$476,398
$73.28 P/Share
|
|
Jan 05
2021
|
Andy Pasternak EVP, Chief Strategy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,513
+38.73%
|
-
|
|
Dec 29
2020
|
Jeffrey W Sherman EVP and Chief Medical Officer |
BUY
Bona fide gift
|
Indirect |
8,679
+4.51%
|
-
|
|
Dec 29
2020
|
Jeffrey W Sherman EVP and Chief Medical Officer |
SELL
Bona fide gift
|
Direct |
8,679
-10.25%
|
-
|
|
Dec 14
2020
|
Miles W Mc Hugh Sr VP & Princ. Acctg Officer |
SELL
Open market or private sale
|
Direct |
1,856
-8.59%
|
$148,480
$80.0 P/Share
|
|
Dec 10
2020
|
Michael A. Des Jardin EVP, Technical Operations |
SELL
Open market or private sale
|
Direct |
5,909
-8.53%
|
$407,721
$69.64 P/Share
|
|
Dec 08
2020
|
Jeffrey W Sherman EVP and Chief Medical Officer |
SELL
Open market or private sale
|
Indirect |
40,764
-9.79%
|
$2,853,480
$70.96 P/Share
|
|
Dec 07
2020
|
Jeffrey W Sherman EVP and Chief Medical Officer |
SELL
Open market or private sale
|
Indirect |
63,078
-8.12%
|
$4,478,538
$71.36 P/Share
|
|
Dec 05
2020
|
Michael A. Des Jardin EVP, Technical Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
2,906
-4.02%
|
$206,326
$71.72 P/Share
|
|
Dec 05
2020
|
Michael A. Des Jardin EVP, Technical Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
5,861
+7.51%
|
-
|
|
Nov 12
2020
|
Miles W Mc Hugh Sr VP & Princ. Acctg Officer |
SELL
Open market or private sale
|
Direct |
12,124
-35.95%
|
$909,300
$75.48 P/Share
|
|
Nov 06
2020
|
Daniel A. Camardo EVP and President, U.S. |
SELL
Open market or private sale
|
Direct |
3,500
-10.2%
|
$266,000
$76.76 P/Share
|
|
Nov 05
2020
|
Jeff Kent Officer |
SELL
Open market or private sale
|
Direct |
47,944
-14.63%
|
$3,787,576
$79.91 P/Share
|
|
Nov 05
2020
|
Barry Moze EVP, Chief Admin. Officer |
SELL
Open market or private sale
|
Direct |
77,500
-12.83%
|
$6,122,500
$79.87 P/Share
|
|
Nov 01
2020
|
Andy Pasternak EVP, Chief Strategy Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,503
-39.46%
|
$407,222
$74.93 P/Share
|
|
Nov 01
2020
|
Andy Pasternak EVP, Chief Strategy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,420
+47.11%
|
-
|
|
Oct 21
2020
|
Jeffrey W Sherman EVP and Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,000
+31.7%
|
$91,000
$7.61 P/Share
|
|
Oct 01
2020
|
Daniel A. Camardo EVP and President, U.S. |
SELL
Payment of exercise price or tax liability
|
Direct |
4,460
-11.5%
|
$356,800
$80.42 P/Share
|
|
Oct 01
2020
|
Daniel A. Camardo EVP and President, U.S. |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+20.5%
|
-
|
|
Sep 17
2020
|
Irina Konstantinovsky EVP, Chief Human Resources Off |
BUY
Exercise of conversion of derivative security
|
Direct |
21,351
+27.12%
|
$298,914
$14.05 P/Share
|
|
Sep 16
2020
|
Irina Konstantinovsky EVP, Chief Human Resources Off |
SELL
Open market or private sale
|
Direct |
8,919
-19.85%
|
$695,682
$78.88 P/Share
|
|
Sep 11
2020
|
Irina Konstantinovsky EVP, Chief Human Resources Off |
SELL
Payment of exercise price or tax liability
|
Direct |
7,095
-13.63%
|
$496,650
$70.54 P/Share
|
|
Sep 11
2020
|
Irina Konstantinovsky EVP, Chief Human Resources Off |
BUY
Grant, award, or other acquisition
|
Direct |
16,014
+23.53%
|
-
|
|
Sep 04
2020
|
Brian K Beeler EVP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
28,143
+20.0%
|
$394,002
$14.88 P/Share
|
|
Aug 24
2020
|
Paul W. Hoelscher EVP, CFO |
SELL
Open market or private sale
|
Indirect |
29,576
-11.34%
|
$2,218,200
$75.98 P/Share
|
|
Aug 06
2020
|
Timothy P Walbert Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
110,000
-2.29%
|
$8,030,000
$73.31 P/Share
|
|
Aug 05
2020
|
Michael G Grey Director |
SELL
Open market or private sale
|
Direct |
1,755
-100.0%
|
$128,115
$73.35 P/Share
|
|
Aug 05
2020
|
Michael G Grey Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,755
+50.0%
|
$5,265
$3.95 P/Share
|
|
Aug 03
2020
|
Vikram Karnani EVP & President, International |
BUY
Exercise of conversion of derivative security
|
Direct |
36,772
+19.91%
|
$551,580
$15.68 P/Share
|
|
Aug 03
2020
|
Gino Santini Director |
BUY
Exercise of conversion of derivative security
|
Direct |
35,795
+36.95%
|
$107,385
$3.22 P/Share
|
|
Aug 02
2020
|
Pascale Witz Director |
SELL
Payment of exercise price or tax liability
|
Indirect |
3,221
-8.51%
|
$196,481
$61.19 P/Share
|
|
Aug 02
2020
|
Pascale Witz Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
8,204
+17.82%
|
-
|
|
Aug 02
2020
|
James Samuel Shannon Director |
SELL
Payment of exercise price or tax liability
|
Indirect |
3,221
-8.75%
|
$196,481
$61.19 P/Share
|
|
Aug 02
2020
|
James Samuel Shannon Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
8,204
+18.22%
|
-
|
|
Jul 22
2020
|
Michael G Grey Director |
SELL
Open market or private sale
|
Direct |
1,755
-100.0%
|
$105,300
$60.0 P/Share
|
|
Jul 22
2020
|
Michael G Grey Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,755
+50.0%
|
$5,265
$3.95 P/Share
|
|
Jul 07
2020
|
Barry Moze EVP, Chief Admin. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
35,076
+6.51%
|
$491,064
$14.15 P/Share
|
|
Jul 07
2020
|
Jeff Kent Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
38,000
+17.59%
|
$190,000
$5.78 P/Share
|
|
Jul 06
2020
|
Jeffrey W Sherman EVP and Chief Medical Officer |
SELL
Open market or private sale
|
Indirect |
9,100
-3.16%
|
$518,700
$57.5 P/Share
|
|
Jul 01
2020
|
Barry Moze EVP, Chief Admin. Officer |
SELL
Open market or private sale
|
Direct |
23,158
-7.06%
|
$1,273,690
$55.02 P/Share
|
|
Jun 25
2020
|
Michael G Grey Director |
SELL
Open market or private sale
|
Direct |
1,755
-100.0%
|
$96,525
$55.0 P/Share
|
|
Jun 25
2020
|
Michael G Grey Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,755
+50.0%
|
$5,265
$3.95 P/Share
|